• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

September 15, 2016

Most People Unaware of Link Between Obesity and Cancer

Author(s):

Lauren Santye, Assistant Editor

High body mass index linked to 10 types of cancer, including cancers of the breast, bowel, esophageal, and womb.

Three out of four people in the United Kingdom are unaware of a link between obesity and cancer, according to a report by Cancer Research UK.

Furthermore, Cancer Research UK and the UK Health Forum estimated that if the obesity epidemic continues, there will be 670,000 additional cancer cases over the next 20 years.

“A quarter of all UK adults are estimated to be obese, and this has a real impact on their risk of developing cancer,” said Julie Sharp, head of health information at Cancer Research UK. “Eating a healthy balanced diet and becoming more active can help people to keep a health weight. And encouraging children and teenagers to do the same can help them keep to a healthy weight later on in life.”

Generally, the nationwide survey found that those from lower socioeconomic backgrounds were less likely to know about the link, with men less likely than women to be aware of the increased risk of cancer caused by obesity.

“Cancer isn’t at the forefront of people’s minds when talking about obesity and that’s really concerning,” said Alison Cox, director of prevention at Cancer Research UK. “Few understand that excess weight increases the risk of several cancers, including some of the most common such as breast cancer.”

More surprisingly, 78% of individuals were unware that obesity was specifically linked to ovarian cancer. In other types of cancer, however, there was increased awareness of the link, with 60% of people aware in bowel cancer, and 55% aware of the link to liver cancer.

“It’s the government’s responsibility to inform the public of the link and also to take action to tackle the obesity epidemic, starting with the health of the nation’s children,” Cox said. “It’s great the government’s childhood obesity plan includes a sugary drinks tax, but it’s not enough to curb the rising tide of ill-health. The government acknowledges that marketing junk food to kids is a problem and has removed these adverts during children’s programming. We also need to see these restrictions during family viewing time before 9pm if we want to make a difference to children’s health.”

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue.
Image credit: Dr_Microbe | stock.adobe.com
Related Content
Advertisement
OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results
June 20th 2025

OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results

Alana Hippensteele, Lead Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
June 19th 2025

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Cell therapy -- Image credit: Giovanni Cancemi | stock.adobe.com
June 19th 2025

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Qianyao Qiu, PharmD, BCOP Grace Ren, BS
High grade follicular lymphoma with marginal zone differentiation. Multiple lymphocytes are undergoing mitosis. Microscopic view.
June 19th 2025

Tafasitamab-Cxix With Rituximab, Lenalidomide Approved by FDA for Relapsed/Refractory Follicular Lymphoma

Luke Halpern, Assistant Editor
Related Content
Advertisement
OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results
June 20th 2025

OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results

Alana Hippensteele, Lead Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
June 19th 2025

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Cell therapy -- Image credit: Giovanni Cancemi | stock.adobe.com
June 19th 2025

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Qianyao Qiu, PharmD, BCOP Grace Ren, BS
High grade follicular lymphoma with marginal zone differentiation. Multiple lymphocytes are undergoing mitosis. Microscopic view.
June 19th 2025

Tafasitamab-Cxix With Rituximab, Lenalidomide Approved by FDA for Relapsed/Refractory Follicular Lymphoma

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.